Mycobacterium Avium Complex Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Mycobacterium Avium Complex Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-05FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)
FDA approved a supplemental application for ARIKAYCE (amikacin liposome inhalation suspension) submitted by Insmed, expanding its label for …
-
FDA approval · 2020-10-19FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)
The FDA approved a supplemental application for ARIKAYCE (amikacin liposome inhalation suspension) from Insmed Incorporated. The action upda…